Genomic medicine in the military

Mauricio De Castro, Leslie G Biesecker, Clesson Turner, Ruth Brenner, Catherine Witkop, Maxwell Mehlman, Chris Bradburne, Robert C Green, Mauricio De Castro, Leslie G Biesecker, Clesson Turner, Ruth Brenner, Catherine Witkop, Maxwell Mehlman, Chris Bradburne, Robert C Green

Abstract

The announcement of the Precision Medicine Initiative was an important step towards establishing the use of genomic information as part of the wider practice of medicine. The US military has been exploring the role that genomic information will have in health care for service members (SMs) and its integration into the continuum of military medicine. An important part of the process is establishing robust protections to protect SMs from genetic discrimination in the era of exome/genome sequencing.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Collins, F. S. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 372, 793–795 (2015).
    1. Biesecker, L. G. & Green, R. C. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med. 371, 1170 (2014).
    1. U.S. Department of Defense. DOD directive 5154.24, Armed Forces Institute of Pathology (2007).
    1. U.S. Department of Defense. Hemoglobin S and Erythrocyte Glucose 6 Phosphate Dehydrogenase Deficiency Testing Program (1981).
    1. Webber, B. J. & Witkop, C. T. Screening for sickle-cell trait at accession to the United States military. Mil. Med. 179, 1184–1189 (2014).
    1. Kark, J. A. , Posey, D. M. , Schumacher, H. R. & Ruehle, C. J. Sickle-cell trait as a risk factor for sudden death in physical training. N. Engl. J. Med. 317, 781–787 (1987).
    1. Memorandum For Dr. Joseph, Assistant Secretary of Defense for Health Affairs, from Gerald F. Fletcher, President for the AFEB, August 13, 1996.
    1. O’Connor, F. G. et al. ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes. Med. Sci. Sports Exerc. 44, 2045–2056 (2012).
    1. Dlamini, N. et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul. Disord. 23, 540–548 (2013).
    1. Corrado, D. , Basso, C. , Rizzoli, G. , Schiavon, M. & Thiene, G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J. Am. Coll. Cardiol. 42, 1959–1963 (2003).
    1. Harmon, K. G. et al. Pathogeneses of sudden cardiac death in national collegiate athletic association athletes. Circ. Arrhythm. Electrophysiol. 7, 198–204 (2014).
    1. Varley, I. et al. RANK/RANKL/OPG pathway: genetic associations with stress fracture period prevalence in elite athletes. Bone 71, 131–136 (2015).
    1. Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565–574 (2013).
    1. Baruch, S. & Hudson, K. Civilian and military genetics: nondiscrimination policy in a post-GINA world. Am. J. Hum. Genet. 83, 435–444 (2008).
    1. Green, R. C. , Lautenbach, D. & McGuire, A. L. GINA, genetic discrimination, and genomic medicine. N. Engl. J. Med. 372, 397–399 (2015).
    1. Mehlman, M. J. & Li, T. Y. Ethical, legal, social, and policy issues in the use of genomic technology by the US Military. J. Law Biosci. 1, 244–280 (2014).
    1. Dorschner, M. O. et al. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am. J. Hum. Genet. 93, 631–640 (2013).
    1. Johnston, J. J. et al. Individualized iterative phenotyping for genome-wide analysis of loss of function mutations. Am. J. Hum. Genet. 96, 913–925 (2015).
    1. Bell, C. J. et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 3, 65ra4 (2011).
    1. Korf, B. R. et al. Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics. Genet. Med. 16, 804–809 (2014).
    1. Vassy, J. L. , Korf, B. R. & Green, R. C. How to know when physicians are ready for genomic medicine. Sci. Transl. Med. 7, 287fs19 (2015).

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe